Drug-Drug Interactions: Future FDA Guidance Will Focus On Specific Modalities; Patient Website To Come
Executive Summary
US FDA took ‘broadest’ approach possible with initial guidance on drug-drug interactions; additional documents will dive into issues specific to different therapeutic areas. But PK/PD modeling and AI alternatives will have to wait.